PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis
- 11 November 2007
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 40 (1) , 51-60
- https://doi.org/10.1038/ng.2007.7
Abstract
Both PU.1 (also called SFPI1), an Ets-family transcription factor, and AML1 (also called RUNX1), a DNA-binding subunit of the CBF transcription factor family, are crucial for the generation of all hematopoietic lineages, and both act as tumor suppressors in leukemia. An upstream regulatory element (URE) of PU.1 has both enhancer and repressor activity and tightly regulates PU.1 expression. Here we show that AML1 binds to functionally important sites within the PU.1 upstream regulatory element and regulates PU.1 expression at both embryonic and adult stages of development. Analysis of mice carrying conditional AML1 knockout alleles and knock-in mice carrying mutations in all three AML1 sites of the URE proximal region demonstrated that AML1 regulates PU.1 both positively and negatively in a lineage dependent manner. Dysregulation of PU.1 expression contributed to each of the phenotypes observed in these mice, and restoration of proper PU.1 expression rescued or partially rescued each phenotype. Thus, our data demonstrate that PU.1 is a major downstream target gene of AML1.Keywords
This publication has 48 references indexed in Scilit:
- Role of Transcription Factors C/EBPa and PU.1 in Normal Hematopoiesis and LeukemiaInternational Journal of Hematology, 2005
- Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemiaOncogene, 2004
- High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasiaBlood, 2004
- In vivo analysis of a developmental circuit for direct transcriptional activation and repression in the same cell by a Runx proteinGenes & Development, 2003
- Disruption of differentiation in human cancer: AML shows the wayNature Reviews Cancer, 2003
- Hematopoietic cytokines, transcription factors and lineage commitmentOncogene, 2002
- Combinatorial Signaling in the Specification of Unique Cell FatesCell, 2000
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999
- Biallelic and Heterozygous Point Mutations in the Runt Domain of theAML1/PEBP2B Gene Associated With Myeloblastic LeukemiasBlood, 1999
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996